CA 125 ANTIGEN - ANVISA Registration 10350840474

Access comprehensive regulatory information for CA 125 ANTIGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10350840474 and manufactured by BODITECH MED INC.. The registration is held by BIOSYS LTDA with validity until Mar 05, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10350840474
2 Related Devices
Registration Details
ANVISA Registration Number: 10350840474
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Família AFIAS CA125
Risk Class III

Registration Details

10350840474

25351434145202437

02220795000179

Company Information

BODITECH MED INC.
South Korea
PT: CORÉIA DO SUL

Dates and Status

Mar 05, 2025

05/03/2035

09/18/2025 19:00:01

Família AFIAS CA125
Risk Class III

Registration Details

10350840474

25351434145202437

02220795000179

Company Information

Dates and Status

Mar 05, 2025

05/03/2035

09/18/2025 19:00:01